Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

Author： Thompson Philip A.   O'Brien Susan M.   Wierda William G.   Ferrajoli Alessandra   Stingo Francesco   Smith Susan C.   Burger Jan A.   Estrov Zeev   Jain Nitin   Kantarjian Hagop M.   Keating Michael J.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|20|3612-3621

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3612-3621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia

By  

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3494-3501

Blackwell Publishing

Access to resources Recommend Favorite

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3958-3964

Blackwell Publishing

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

By  

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 701-709

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3399-3405

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Copy Number Profiles Correlate with Outcome in Colorectal Cancer Patients Treated with Fluoropyrimidine/Antifolate-based Regimens

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 956-965

Bentham Science Publishers

Access to resources Recommend Favorite